Showing 3,441 - 3,460 results of 5,389 for search 'reaching function', query time: 0.11s Refine Results
  1. 3441
  2. 3442

    A Multidata Approach to Open Clusters: Roslund 3 and Ruprecht 174 in CCD UBV and Gaia DR3 Context by Hülya Karagöz, Talar Yontan, Selçuk Bilir, Olcay Plevne, Tansel Ak, Serap Ak, Remziye Canbay, Timothy Banks

    Published 2025-01-01
    “…The present-day mass function slopes were found to be 1.18  ±  0.13 for Roslund 3 and 1.53  ±  0.30 for Ruprecht 174, consistent with the canonical Salpeter value within uncertainties. …”
    Get full text
    Article
  3. 3443

    Hybrid kinetic analysis of FR-2 and FR-4 type printed circuit boards: A thermogravimetric analysis by Anuj Thukral, Adhithiya Venkatachalapati Thulasiraman, Arun K. Vuppaladadiyam, Savan Kumar Patel, Manoj Kumar Jena, Kalpit Shah, Neha Gupta, Rahul Saha, Anuushka Pal, Parveen Saini

    Published 2025-03-01
    “…For FR-4 NMFs, the reaction function f(α) is between random nucleation with three nuclei on the individual particle (F3) and random nucleation with one nucleus on the individual particle (F1) over the selected range of conversion. …”
    Get full text
    Article
  4. 3444
  5. 3445

    Associations of Urine Epidermal Growth Factor With Kidney and Cardiovascular Outcomes in Individuals With CKD in SPRINT by Merve Postalcioglu, Ronit Katz, Simon B. Ascher, Trenton Hall, Pranav S. Garimella, Stein I. Hallan, Joachim H. Ix, Michael G. Shlipak

    Published 2024-11-01
    “…Introduction: Urine epidermal growth factor (uEGF) has been found to be inversely associated with kidney function loss, whereas its associations with cardiovascular disease (CVD) and mortality have not been studied. …”
    Get full text
    Article
  6. 3446

    Prognostic value of left atrial strain in acute and chronic heart failure: A meta‐analysis by Maria Concetta Pastore, Mariangela Vigna, Andrea Saglietto, Maria Alma Iuliano, Giulia Elena Mandoli, Andrea Stefanini, Chiara Carrucola, Laura Fusini, Luna Cavigli, Flavio D'ascenzi, Marta Focardi, Serafina Valente, Matteo Cameli

    Published 2025-08-01
    “…Over a median follow‐up of 903 [321; 1062] days, 2688 patients reached the primary endpoint (944 all‐cause mortality and 1963 hospitalizations). …”
    Get full text
    Article
  7. 3447

    Salvia deserti Decne., an endemic and rare subshrub from Arabian desert: antidiabetic and antihyperlipidemic effects of leaf hydroethanolic extracts by Arbi Guetat, Slimen Selmi, Abdelrhman T. Abdelwahab, Marwa A. Abdelfattah, Abd Ealrhman M. Elhaj, Roaa T. Mogharbel, M. J. A. Abualreish, Abdullah F. Alanazi, Karim Hosni, Naceur Mejri, Abdennacer Boulila

    Published 2025-02-01
    “…IntroductionDiabetes is a major health issue that has reached alarming levels worldwide. Although their effectiveness, the antidiabetic drugs have many side effects such as cardiovascular diseases, kidney failure, and hepatic complications. …”
    Get full text
    Article
  8. 3448

    Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study by Vladimir Gabai, Evgeny Bakin, Maxim Langs, Robert Devlin, Sergei Krasny, Yauheni Baranou, Sergey Polyakov, Maksim Patapovich, Sergey Gvozdev, Maksim Kardash, Aliaksei Bazyleuski, Andrei Yeliseyeu, Egor Lelikov, Andrei Borodko, Alexander Shneider, Alexander Shneider

    Published 2025-06-01
    “…IntroductionOsteoarthritis (OA) is a progressive degenerative disease of synovial joints which is highly prevalent in dogs and results in lameness, loss of joint function and mobility, chronic pain, and reduced quality of life. …”
    Get full text
    Article
  9. 3449
  10. 3450
  11. 3451
  12. 3452

    Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy? by Georgios Tsioulos, Natalia G. Vallianou, Alexandros Skourtis, Maria Dalamaga, Evangelia Kotsi, Sofia Kargioti, Nikolaos Adamidis, Irene Karampela, Iordanis Mourouzis, Dimitris Kounatidis

    Published 2024-12-01
    “…Preclinical models indicate that vaccines targeting specific atherosclerosis-related autoantigens can slow disease progression while preserving systemic immune function. In this context, numerous experimental studies have advanced the understanding of vaccine development by exploring diverse targeting pathways. …”
    Get full text
    Article
  13. 3453

    Association of body composition with left ventricular remodeling and outcomes in diabetic heart failure with reduced ejection fraction: assessment of sarcopenic obesity using cardi... by Ke Shi, Ge Zhang, Rong Xu, Xue-Ming Li, Li Jiang, Yue Gao, Hua-Yan Xu, Yuan Li, Ying-Kun Guo, Zhi-Gang Yang

    Published 2025-02-01
    “…Obesity in conjunction with a SMI lower than the median is referred to as SO. The LV volume and function, as well as the systolic strain, were measured. …”
    Get full text
    Article
  14. 3454
  15. 3455

    A prospective randomized controlled trial comparing biphasic cartilage repair implant with microfracture in small chondral lesions of knee: findings at five-year-follow-up by Yao-Yi Kuo, Si-Qi Chiu, Wen-Pei Chang, Chih-Yu Chen, Chih-Hwa Chen, Chen-Kun Liaw, Cheng-Aun Tan, Pei-Wei Weng

    Published 2025-01-01
    “…Abstract Background Full-thickness cartilage defects have a significant impact on the function of joints in young adults, and the treatment of cartilage defects has been a challenge, as cartilage tissue is an avascular tissue. …”
    Get full text
    Article
  16. 3456

    Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer’s Disease by Sun C, Sha S, Shan Y, Gao X, Li L, Xing C, Guo Z, Du H

    Published 2025-05-01
    “…In a 5xFAD mouse model, Exos selectively targeted microglial and neuronal cells after nasal delivery under the action of neural cell-targeting peptide rabies virus glycoprotein 29 (RVG29).Results: BACE1 siRNA and berberine (BBR) loading enhanced the effectiveness of Exos in improving cognitive function, promoting nerve repair and regeneration, reducing inflammatory cytokine expression, and suppressing glial responses. …”
    Get full text
    Article
  17. 3457

    Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study by Mi Mi Ko, Se Won Na, Jin-Mu Yi, Ho Jang, Chang Min Choi, Seung Hyeun Lee, Sung Yong Lee, Mi-Kyung Jeong

    Published 2025-07-01
    “…Immune profiling suggested that BJIKT may activated CD4 + T cells, increased the proportion of CD3 + CD4 + cells, and enhanced T cell function while reducing immune exhaustion. Notably, a statistically significant decrease in PD-1 + CD8 + T cells was observed, while the reduction in PD-1 + CD4 + T cells did not reach significance. …”
    Get full text
    Article
  18. 3458

    Mavacamten maintenance dose determination: insights into individualised therapy for hypertrophic cardiomyopathy by Kawa Mohemed, Smita Scholtz, Volker Rudolph, Jan-Christian Reil, Max Potratz, Cédric Coppée, Vasco Sequeira, Werner Scholtz

    Published 2025-03-01
    “…Mean time to reach maintenance dose was 14 weeks, with the necessity of dose adjustments in more than 50% of cases.Conclusion Mavacamten therapy is safe and effective in the initiating phase. …”
    Get full text
    Article
  19. 3459
  20. 3460

    Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, S. I. Glukhova

    Published 2022-12-01
    “…It is a combination of features on first visit – oligoarthritis, moderate activity, absent of entesitis, dactylitis, nail psoriasis, significant impact on function and fatigue – that constitutes a clinical prognostic factors for achievement MDA after 12 mo of treatment in pts with early PsA according T2T.…”
    Get full text
    Article